Resistance Pattern of Ciprofloxacin Against Different Pathogens

Objectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To in...

Full description

Bibliographic Details
Main Authors: Syeda Q. Ali, Ale Zehra, Baquar S. Naqvi, Shahjahan Shah, Rabia Bushra
Format: Article
Language:English
Published: Oman Medical Specialty Board 2010-10-01
Series:Oman Medical Journal
Subjects:
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultext
id doaj-6b4a971954da4d68bc18ba861ad187c1
record_format Article
spelling doaj-6b4a971954da4d68bc18ba861ad187c12020-11-24T21:20:14ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042010-10-01254294298Resistance Pattern of Ciprofloxacin Against Different PathogensSyeda Q. AliAle ZehraBaquar S. NaqviShahjahan ShahRabia BushraObjectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To investigate the present status of antimicrobial resistance against ciprofloxacin, five hundred and twenty four clinical isolates of Escherichia coli (30%), Staphylococcus aureus (33%), Salmonella typhi (9%), Klebsiella pneumonia (14%) and Pseudomonas aeruginosa (14%) were collected during study from January, 2008 to February, 2009 from different pathological laboratories running in and out side hospitals located in Karachi, Pakistan. These pathogens were isolated from specimens of both in and out patients. The in-vitro antimicrobial activity of ciprofloxacin was carried out by Disc Diffusion Method (Kirby-Bauer test).Results: Showed that ciprofloxacin is 27.02%, 21.95%, 16.66%, 72.22% and 44.44% resistant to Escherichia coli, Staphylococcus aureus, Salmonella typhi, Klebsiella pneumonia and Pseudomonas aeruginosa respectively.Conclusion: It is concluded that these clinical isolates have started developing resistance against ciprofloxacin due to its irrational and inappropriate use. Continuous surveillance is crucial to monitor the antimicrobial resistance among pathogens.http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultextpathogensciproflaxin
collection DOAJ
language English
format Article
sources DOAJ
author Syeda Q. Ali
Ale Zehra
Baquar S. Naqvi
Shahjahan Shah
Rabia Bushra
spellingShingle Syeda Q. Ali
Ale Zehra
Baquar S. Naqvi
Shahjahan Shah
Rabia Bushra
Resistance Pattern of Ciprofloxacin Against Different Pathogens
Oman Medical Journal
pathogens
ciproflaxin
author_facet Syeda Q. Ali
Ale Zehra
Baquar S. Naqvi
Shahjahan Shah
Rabia Bushra
author_sort Syeda Q. Ali
title Resistance Pattern of Ciprofloxacin Against Different Pathogens
title_short Resistance Pattern of Ciprofloxacin Against Different Pathogens
title_full Resistance Pattern of Ciprofloxacin Against Different Pathogens
title_fullStr Resistance Pattern of Ciprofloxacin Against Different Pathogens
title_full_unstemmed Resistance Pattern of Ciprofloxacin Against Different Pathogens
title_sort resistance pattern of ciprofloxacin against different pathogens
publisher Oman Medical Specialty Board
series Oman Medical Journal
issn 1999-768X
2070-5204
publishDate 2010-10-01
description Objectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To investigate the present status of antimicrobial resistance against ciprofloxacin, five hundred and twenty four clinical isolates of Escherichia coli (30%), Staphylococcus aureus (33%), Salmonella typhi (9%), Klebsiella pneumonia (14%) and Pseudomonas aeruginosa (14%) were collected during study from January, 2008 to February, 2009 from different pathological laboratories running in and out side hospitals located in Karachi, Pakistan. These pathogens were isolated from specimens of both in and out patients. The in-vitro antimicrobial activity of ciprofloxacin was carried out by Disc Diffusion Method (Kirby-Bauer test).Results: Showed that ciprofloxacin is 27.02%, 21.95%, 16.66%, 72.22% and 44.44% resistant to Escherichia coli, Staphylococcus aureus, Salmonella typhi, Klebsiella pneumonia and Pseudomonas aeruginosa respectively.Conclusion: It is concluded that these clinical isolates have started developing resistance against ciprofloxacin due to its irrational and inappropriate use. Continuous surveillance is crucial to monitor the antimicrobial resistance among pathogens.
topic pathogens
ciproflaxin
url http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultext
work_keys_str_mv AT syedaqali resistancepatternofciprofloxacinagainstdifferentpathogens
AT alezehra resistancepatternofciprofloxacinagainstdifferentpathogens
AT baquarsnaqvi resistancepatternofciprofloxacinagainstdifferentpathogens
AT shahjahanshah resistancepatternofciprofloxacinagainstdifferentpathogens
AT rabiabushra resistancepatternofciprofloxacinagainstdifferentpathogens
_version_ 1726003288388665344